Bertrand William C JR (CIK 0001291937)

Latest company ownership

Shares held
986,352
Last filed at
Aug 29, 2025
Confidence Score
45.7
2025Q4
Confidence Score History
2019Q1 2025Q4
ARDX - ARDELYX, INC.
Role: Director
Shares held
54,059
Last filed at
Jun 23, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 28, 2025 Aug 29, 2025 Adaptimmune Therapeutics PLC COO Sell 27.5 -207,000 -17.35% ✗ $2.1K
Jan 17, 2025 Jan 17, 2025 Adaptimmune Therapeutics PLC COO Sell 47.5 -5,584 -42.65% ✗ $3.2K
Jan 13, 2025 Jan 15, 2025 Adaptimmune Therapeutics PLC COO Sell 46.3 -19,542 -41.79% ✗ $11.4K
Jan 16, 2024 Jan 17, 2024 Adaptimmune Therapeutics PLC COO Sell 46.3 -23,589 -40.26% ✗ $16.4K
Jan 11, 2024 Jan 12, 2024 Adaptimmune Therapeutics PLC COO Sell 47.5 -9,229 -39.77% ✗ $7.8K
Jan 17, 2023 Jan 17, 2023 Adaptimmune Therapeutics PLC COO Sell 47.5 -4,440 -37.94% ✗ $8.2K
Jan 11, 2023 Jan 12, 2023 Adaptimmune Therapeutics PLC COO Sell 46.3 -8,816 -37.99% ✗ $15.2K
Jan 4, 2023 Jan 4, 2023 Adaptimmune Therapeutics PLC COO Sell 47.5 -3,584 -38.27% ✗ $6.1K
Jan 18, 2022 Jan 18, 2022 Adaptimmune Therapeutics PLC COO Sell 46.3 -4,368 -37.32% ✗ $13.9K
Jan 11, 2022 Jan 13, 2022 Adaptimmune Therapeutics PLC COO Sell 46.3 -6,018 -37.34% ✗ $21.4K
Jan 4, 2022 Jan 5, 2022 Adaptimmune Therapeutics PLC COO Sell 46.3 -3,490 -37.27% ✗ $14.2K
Jul 2, 2021 Jul 2, 2021 Adaptimmune Therapeutics PLC COO Sell 46.3 -4,375 -37.38% ✗ $18.7K
Jan 12, 2021 Jan 12, 2021 Adaptimmune Therapeutics PLC COO Sell 46.3 -2,234 -37.22% ✗ $13.7K
Jan 4, 2021 Jan 5, 2021 Adaptimmune Therapeutics PLC COO Sell 46.3 -3,499 -37.37% ✗ $18.6K
Dec 14, 2020 Dec 15, 2020 Adaptimmune Therapeutics PLC COO Buy 95.0 +207,000 266.04% ✗ $143.8K
Jan 14, 2020 Jan 15, 2020 Adaptimmune Therapeutics PLC COO Sell 46.3 -2,397 -39.94% ✗ $12.3K
Jan 6, 2020 Jan 7, 2020 Adaptimmune Therapeutics PLC COO Sell 47.5 -3,731 -39.85% ✗ $4.5K
Jan 14, 2019 Jan 16, 2019 Adaptimmune Therapeutics PLC COO Sell 46.3 -2,271 -37.84% ✗ $12.2K
Dec 17, 2015 Dec 21, 2015 ARDELYX, INC. Director Buy 95.0 +5,000 100.00% ✗ $100K